Cancer of the corpus uteri

被引：63

作者：

Amant, Frederic ^{[1
]}

Mirza, Mansoor Raza ^{[2
]}

Koskas, Martin ^{[3
]}

Creutzberg, Carien L. ^{[4
]}

机构：

[1] Univ Hosp Gasthuisberg, Div Gynecol Oncol, Leuven, Belgium

[2] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark

[3] Hop Xavier Bichat, Div Gynecol Oncol, Paris, France

[4] Leiden Univ, Dept Clin Oncol, Med Ctr, Leiden, Netherlands

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2015年 / 131卷

关键词：

PHASE-III TRIAL; ADVANCED ENDOMETRIAL CARCINOMA; ROUTINE FOLLOW-UP; EXTERNAL-BEAM RADIOTHERAPY; ENDOTHELIAL GROWTH-FACTOR; STAGE-I; LONG-TERM; ADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; INTERMEDIATE-RISK;

D O I：

10.1016/j.ijgo.2015.06.005

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

[No abstract available]

引用

页码：S96 / S104

页数：9

共 112 条

[1]

AALDERS J, 1980, OBSTET GYNECOL, V56, P419

[2]

Endometrial cancer - Revisiting the importance of pelvic and para aortic lymph nodes [J].

Aalders, Jan G. ;

Thomas, Gillian .

GYNECOLOGIC ONCOLOGY, 2007, 104 (01) :222-231

[3]

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group [J].

Aapro, MS ;

van Wijk, FH ;

Bolis, G ;

Chevallier, B ;

van der Burg, MEL ;

Poveda, A ;

de Oliveira, CF ;

Tumolo, S ;

di Palumbo, VS ;

Piccart, M ;

Franchi, M ;

Zanaboni, F ;

Lacave, AJ ;

Fontanelli, R ;

Favalli, G ;

Zola, P ;

Guastalla, JP ;

Rosso, R ;

Marth, C ;

Nooij, M ;

Presti, M ;

Scarabelli, C ;

Splinter, TAW ;

Ploch, E ;

Beex, LVA ;

Huinink, WT ;

Forni, M ;

Melpignano, M ;

Blake, P ;

Kerbrat, P ;

Mendiola, C ;

Cervantes, A ;

Goupil, A ;

Harper, PG ;

Madronal, C ;

Namer, M ;

Scarfone, G ;

Stoot, JEGM ;

Teodorovic, I ;

Coens, C ;

Vergote, I ;

Vermorken, JB .

ANNALS OF ONCOLOGY, 2003, 14 (03) :441-448

[4]

Endometrial carcinoma - Relative effectiveness of adjuvant irradiation vs therapy reserved for relapse [J].

Ackerman, I ;

Malone, S ;

Thomas, G ;

Franssen, E ;

Balogh, J ;

Dembo, A .

GYNECOLOGIC ONCOLOGY, 1996, 60 (02) :177-183

[5]

Agboola OO, 1997, CAN MED ASSOC J, V157, P879

[6]

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study [J].

Aghajanian, Carol ;

Sill, Michael W. ;

Darcy, Kathleen M. ;

Greer, Benjamin ;

McMeekin, D. Scott ;

Rose, Peter G. ;

Rotmensch, Jacob ;

Barnes, Mack N. ;

Hanjani, Parviz ;

Leslie, Kimberly K. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) :2259-2265

[7]

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer [J].

Akram, T ;

Maseelall, P ;

Fanning, J .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (05) :1365-1367

[8]

Is there any value in the long term follow up of women treated for endometrial cancer? [J].

Allsop, JR ;

Preston, J ;

Crocker, S .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (01) :122-122

[9]

Phase II trial of combination bevacizumab and temsirolimus in the treatment of A recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study [J].

Alvarez, Edwin A. ;

Brady, William E. ;

Walker, Joan L. ;

Rotmensch, Jacob ;

Zhou, Xun C. ;

Kendrick, James E. ;

Yamada, S. Diane ;

Schilder, Jeanne M. ;

Cohn, David E. ;

Harrison, Charles R. ;

Moore, Kathleen N. ;

Aghajanian, Carol .

GYNECOLOGIC ONCOLOGY, 2013, 129 (01) :22-27

[10]

Endometrial cancer [J].

Amant, F ;

Moerman, P ;

Neven, P ;

Timmerman, D ;

Van Limbergen, E ;

Vergote, I .

LANCET, 2005, 366 (9484) :491-505

← 1 2 3 4 5 6 7 8 9 10 →